امور مالی

Novo Nordisk stock support test at $37.43: Technical outlook

Novo Nordisk stock target cut at Citi on lack of margin growth

Former GN executive to lead Nordic expansion of AI cell-therapy company that took over Novo program

UBS Called Novo Nordisk a 'Value Trap.' Here's the Other Side of That Argument.